Clinical Trial Update: Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tirzepatide with intensive lifestyle therapy for obesity and metabolic health in Latino adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Disease
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Obesity, Metabolic Disease | Phase 4 | Status: WITHDRAWN